JPMorgan Chase & Co. Begins Coverage on Ardent Health Partners (NYSE:ARDT)

JPMorgan Chase & Co. assumed coverage on shares of Ardent Health Partners (NYSE:ARDT) in a report issued on Monday morning, MarketBeat Ratings reports. The brokerage issued a neutral rating and a $18.00 target price on the stock.

ARDT has been the topic of several other research reports. Mizuho started coverage on Ardent Health Partners in a research note on Monday. They issued an outperform rating and a $20.00 price objective on the stock. Truist Financial started coverage on Ardent Health Partners in a research note on Monday. They issued a buy rating and a $21.00 price objective on the stock. Finally, SVB Leerink started coverage on Ardent Health Partners in a research note on Monday. They issued an outperform rating and a $23.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of Buy and a consensus target price of $21.70.

Ardent Health Partners Stock Performance

Shares of NYSE ARDT opened at $16.04 on Monday. Ardent Health Partners has a 52 week low of $15.00 and a 52 week high of $18.16.

Ardent Health Partners Company Profile

We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.